Newsroom | 71251 results

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Beren Therapeutics P.B.C., the parent company of Mandos LLC and a leader in cholesterol trafficking biology and cyclodextrin-based therapeutics, today announced that the company will present six posters at the 2026 Michael, Marcia, and Christa Parseghian Scientific Conference for Niemann-Pick Type C Research, sponsored by the family of former Notre Dame head football coach Ara Parseghian, taking place May 30 through June 2 in Tucson, Arizona. The posters...

LAKE FOREST, Calif.--(BUSINESS WIRE)--Zef Scientific, Inc. (ZefSci), the leading North America independent service provider of multivendor LCMS systems, today announced a partnership with Boston based Peak Life Science Advisors, LLC with industry expert Rick Carberry. Recently acquired by Shimadzu Scientific Instruments (SSI), ZefSci is looking to help fuel its growth through new partnership development within the LCMS “ecosystem”. Providing expert sales, marketing and in-lab service support fo...

NEW YORK--(BUSINESS WIRE)--The Pershing Square Foundation (the “Foundation”) today announced $6 million in funding to support eight pioneering scientists advancing innovative ovarian cancer research across the United States. For more than a decade, the Foundation has advanced transformative cancer research through the Pershing Square Sohn Cancer Research Alliance (“PSSCRA”). Building on its longstanding commitment to cancer research and women’s health, the Foundation is now in the second year o...

TORONTO--(BUSINESS WIRE)--Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTC: MVMDF) is pleased to report on the advancement of its patented Quicksome™ sublingual delivery platform as part of the Company’s strategy to position Quicksome™ as a differentiated delivery solution within the evolving compounded peptide marketplace across North and South America. Over the past six months, the Company has expanded its internal formulation capabilities following investments in l...

PRINCETON, N.J.--(BUSINESS WIRE)--BMS Announces CELMoD Mezigdomide Reduces Risk of Disease Progression or Death by More than 50% vs. Standard of Care in.......

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced unprecedented seven-year follow-up results from the Phase 3 CROWN trial evaluating LORBRENA® (lorlatinib, a third-generation ALK inhibitor, available in Europe under the brand name LORVIQUA®) versus XALKORI® (crizotinib) in people with previously untreated, anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC). At seven years, patients treated with LORBRENA had a 55% likelihood of re...

THE WOODLANDS, Texas--(BUSINESS WIRE)--Research presented by The US Oncology Network found that new patient consult models led by advanced practice providers can accelerate access to care....

EDMONTON, Alberta--(BUSINESS WIRE)--Youth Science Canada presented the top awards at the 2026 Canada-Wide Science Fair (CWSF) on Thursday evening in Edmonton, Alta....

EDMONTON, Alberta--(BUSINESS WIRE)--Sciences jeunesse Canada a présenté les grands prix de l'Expo-sciences pancanadienne (ESPC) 2026 jeudi soir à Edmonton (Alb.), où 390 finalistes de partout au Canada ont présenté 344 projets et se sont disputé près de 2 millions de dollars en prix, dans le cadre du plus grand événement en STIM pour les jeunes au Canada. Faits saillants : Liam Desre, de Kingston (Ont.), a remporté le Prix du meilleur projet — Découverte pour avoir proposé un nouveau modèle de...

AUSTIN, Texas--(BUSINESS WIRE)--PanTher Therapeutics (“PanTher” or the “Company”), a clinical-stage company redefining early cancer treatment with therapeutic implants administered directly at the tumor site, today announced that it has concluded the dose escalation portion of its Phase 1b clinical trial of PTM-101 in pancreatic ductal adenocarcinoma (PDAC). PanTher has identified the PTM-101 400mg paclitaxel-containing implant as the recommended Phase 2 dose (RP2D) in combination with neoadjuv...